News Conference News VIVA 2017 ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA L.A. McKeown September 15, 2017
Presentation VIVA 2017 Results from the IN.PACT SFA Randomized Trial Presenter: Peter A. Schneider September 15, 2017
Presentation VIVA 2017 Two-year Results from the IN.PACT Global Study Presenter: Thomas Zeller September 14, 2017
Presentation VIVA 2017 Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017
News Conference News VIVA 2017 EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017
News Conference News VIVA 2017 DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease L.A. McKeown September 13, 2017
Presentation ESC 2017 The Viborg Vascular (VIVA) Randomised Screening Trial Presenter: Jes Lindholt August 29, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
Presentation LAA 2017 Electrical/Ablation Approaches to AFib: Competitive or Complementary With LAA Closure? Presenter: Vivek Y. Reddy July 21, 2017
News Daily News New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment Todd Neale February 17, 2017
News Conference News ISET 2017 Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs? Caitlin E. Cox February 17, 2017
News Conference News ISET 2017 Targeted Delivery of Dexamethasone Combats Restenosis in Femoropopliteal Lesions: DANCE Trial Caitlin E. Cox February 15, 2017
News Opinion Editor's Corner Las Noticias y Blogs Más Populares de TCTMD en 2016 Shelley Wood December 29, 2016
News Daily News Las Dudas en torno al Equilibrio Riesgos-Beneficios para los Filtros VCI Siguen Irritando a los Médicos Caitlin E. Cox November 17, 2016
News Conference News VIVA 2016 Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option L.A. McKeown October 12, 2016
News Conference News VIVA 2016 Bioresorbable Scaffold Shows Sustained Promise in Superficial Femoral and Iliac Artery Lesions L.A. McKeown September 22, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016
News Conference News VIVA 2016 Carotid Stent Fractures Pose Very Little Threat to Patients, Study Finds L.A. McKeown September 21, 2016